Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM)

Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients. Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients. Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients. Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients. Biogaia Signs Agreement With Novartis Consumer Health SA BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies. Biogaia Signs Agreement With Novartis Consumer Health SA BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies. Biogaia Signs Agreement With Novartis Consumer Health SA BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies. Biogaia Signs Agreement With Novartis Consumer Health SA BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Dairies Targeting Value-Added Milk Market Sales of value-added milk expanded by 39% in 2005, now comprising over 6% of drinking milk sales in the UK. Dairies Targeting Value-Added Milk Market Sales of value-added milk expanded by 39% in 2005, now comprising over 6% of drinking milk sales in the UK. Dairies Targeting Value-Added Milk Market Sales of value-added milk expanded by 39% in 2005, now comprising over 6% of drinking milk sales in the UK. Dairies Targeting Value-Added Milk Market Sales of value-added milk expanded by 39% in 2005, now comprising over 6% of drinking milk sales in the UK. Ocean Spray Appoints New Senior Manager For European Sales Ocean Spray ITG has announced the appointment of Lee Doleman as senior manager, European sales, joining the company from his position as commercial director of J. O. Sims, one of the UK's leading food ingredient suppliers. Ocean Spray Appoints New Senior Manager For European Sales Ocean Spray ITG has announced the appointment of Lee Doleman as senior manager, European sales, joining the company from his position as commercial director of J. O. Sims, one of the UK's leading food ingredient suppliers. Ocean Spray Appoints New Senior Manager For European Sales Ocean Spray ITG has announced the appointment of Lee Doleman as senior manager, European sales, joining the company from his position as commercial director of J. O. Sims, one of the UK's leading food ingredient suppliers. Ocean Spray Appoints New Senior Manager For European Sales Ocean Spray ITG has announced the appointment of Lee Doleman as senior manager, European sales, joining the company from his position as commercial director of J. O. Sims, one of the UK's leading food ingredient suppliers. Ocean Spray Appoints New Senior Manager For European Sales Ocean Spray ITG has announced the appointment of Lee Doleman as senior manager, European sales, joining the company from his position as commercial director of J. O. Sims, one of the UK's leading food ingredient suppliers. Forbes Medi-Tech Announces Launch of Cholesterol-Lowering Milk Drink with Reducol(tm) at Tesco Stores Ltd. Tesco Stores Ltd (Tesco), has started selling a milk drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The milk drink is marketed under the Tesco private label brand. Forbes Medi-Tech Announces Launch of Cholesterol-Lowering Milk Drink with Reducol(tm) at Tesco Stores Ltd. Tesco Stores Ltd (Tesco), has started selling a milk drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The milk drink is marketed under the Tesco private label brand. Forbes Medi-Tech Announces Launch of Cholesterol-Lowering Milk Drink with Reducol(tm) at Tesco Stores Ltd. Tesco Stores Ltd (Tesco), has started selling a milk drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The milk drink is marketed under the Tesco private label brand. Forbes Medi-Tech Announces Launch of Cholesterol-Lowering Milk Drink with Reducol(tm) at Tesco Stores Ltd. Tesco Stores Ltd (Tesco), has started selling a milk drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The milk drink is marketed under the Tesco private label brand. Forbes Medi-Tech Announces Launch of Cholesterol-Lowering Milk Drink with Reducol(tm) at Tesco Stores Ltd. Tesco Stores Ltd (Tesco), has started selling a milk drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The milk drink is marketed under the Tesco private label brand. Forbes Medi-Tech Announces Launch of Cholesterol-Lowering Milk Drink with Reducol(tm) at Tesco Stores Ltd. Tesco Stores Ltd (Tesco), has started selling a milk drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The milk drink is marketed under the Tesco private label brand. Forbes Medi-Tech Announces Launch of Cholesterol-Lowering Milk Drink with Reducol(tm) at Tesco Stores Ltd. Tesco Stores Ltd (Tesco), has started selling a milk drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The milk drink is marketed under the Tesco private label brand. Solbar Industries Launches New Website Company announces the launch of its new, interactive and user-friendly website at www.solbar.com displaying its range of soy products. Solbar Industries Launches New Website Company announces the launch of its new, interactive and user-friendly website at www.solbar.com displaying its range of soy products. Solbar Industries Launches New Website Company announces the launch of its new, interactive and user-friendly website at www.solbar.com displaying its range of soy products. Solbar Industries Launches New Website Company announces the launch of its new, interactive and user-friendly website at www.solbar.com displaying its range of soy products. Solbar Industries Launches New Website Company announces the launch of its new, interactive and user-friendly website at www.solbar.com displaying its range of soy products. Solbar Industries Launches New Website Company announces the launch of its new, interactive and user-friendly website at www.solbar.com displaying its range of soy products. Biogaia Signs Agreement With Forest Laboratories Company has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited giving Forest the exclusive rights to sell BioGaia's Reuteri Drops in Great Britain and Ireland. Biogaia Signs Agreement With Forest Laboratories Company has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited giving Forest the exclusive rights to sell BioGaia's Reuteri Drops in Great Britain and Ireland. Biogaia Signs Agreement With Forest Laboratories Company has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited giving Forest the exclusive rights to sell BioGaia's Reuteri Drops in Great Britain and Ireland. Biogaia Signs Agreement With Forest Laboratories Company has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited giving Forest the exclusive rights to sell BioGaia's Reuteri Drops in Great Britain and Ireland. Biogaia Signs Agreement With Forest Laboratories Company has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited giving Forest the exclusive rights to sell BioGaia's Reuteri Drops in Great Britain and Ireland. Enzymotec Launches SharpPS gold Comany introduces SharpPS gold, a PS-DHA conjugate to its line of cognition products. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Milan, February 9th, 2006 - An olive fruit extract, which will help keep skin looking beautiful as well as healthy inside and out, has been studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. Five years of co-research and close cooperation have brought about the development and commercialization of OPEXTAN^TM. "We are proud of our long-term collaboration with Kanebo Cosmetics. Both companies have shared their expertise to achieve the success of this novel ingredient", says Christian Artaria, Indena's Marketing Director. The olive varieties were screened and selected by Indena, whose botanists pinpointed the best harvesting period and methods to ensure the highest levels of verbascoside and other polyphenols. Indena also managed the process of industrialization, whilst the final efficacy trials were conducted by Kanebo Cosmetics. "Preclinical and clinical evidence of its free radical scavenging capacity was obtained successfully in our laboratories " - declared Dr. Takeshi Ikemoto, the Kanebo Research and Development Manager. "The link between skin dryness and blood glucose levels, also balanced by OPEXTAN^TM, was investigated together with Japanese researchers in the Tohoku University, Miyagi." One of the most characteristic olive polyphenols, Verbascoside, has been used as the reference compound in the manufacture of OPEXTAN^TM. It exerts a free radical scavenging activity which has a direct impact on skin health, preventing oxidative damage associated with wrinkle formation, skin thinning and dehydration. Patents on the OPEXTAN^TM based composition activity have been filed jointly by Indena and Kanebo Cosmetics: they claim the activity of the novel composition on UV damage, wrinkle formation and hair tonic. Indena will promote OPEXTAN^TM worldwide apart from in Japan, where it is already marketed under the newly launched cosmetic and supplement line "Bella Vita". COMPANY PROFILE: Indena is the world's leading company dedicated to the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health food and cosmetics industries. The key to Indena's success is its research, covering: the screening of medicinal plants for their pharmacological benefits; the identification of new active principles; and the development of extraction and purification systems at the cutting-edge of industrial application. Backed up by 85 years of botanical experience, the phyto-chemical research is carried out in Indena's own Settala Research Center, near Milan. Indena also co-operates with the world's most prestigious universities and private research institutions in the biological assessment of safety and effectiveness up to clinical phase I. The company, with around 800 employees, including 10% dedicated to full-time research, manages cultivation, manufacturing, and distribution operations in more than 40 countries throughout the world. The Company's experts communicate and interact constantly with the major international regulatory authorities such as WHO, EMEA, and ESCOP, and work with all the main pharmacopoeias.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software